Aurélie Drouet

742 total citations
12 papers, 269 citations indexed

About

Aurélie Drouet is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Aurélie Drouet has authored 12 papers receiving a total of 269 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Oncology. Recurrent topics in Aurélie Drouet's work include Immunotherapy and Immune Responses (4 papers), Immune Cell Function and Interaction (4 papers) and CAR-T cell therapy research (3 papers). Aurélie Drouet is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Immune Cell Function and Interaction (4 papers) and CAR-T cell therapy research (3 papers). Aurélie Drouet collaborates with scholars based in France, Italy and Australia. Aurélie Drouet's co-authors include Thierry Frébourg, Mohamad Hamieh, Pascaline Gaildrat, Alexandra Martins, Omar Soukarieh, Stéphanie Baert‐Desurmont, Mario Tosi, Jean‐Baptiste Latouche, Jean‐Michel Flaman and Richard Sesboüé and has published in prestigious journals such as The Journal of Immunology, Frontiers in Immunology and PLoS Genetics.

In The Last Decade

Aurélie Drouet

12 papers receiving 254 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aurélie Drouet France 8 141 61 55 50 43 12 269
Małgorzata Krześniak Poland 11 237 1.7× 28 0.5× 40 0.7× 108 2.2× 89 2.1× 23 325
Teri M. Plona United States 5 272 1.9× 48 0.8× 17 0.3× 59 1.2× 79 1.8× 6 365
Jin Woo Park South Korea 11 357 2.5× 29 0.5× 24 0.4× 52 1.0× 61 1.4× 19 406
Christine von Klitzing Germany 6 244 1.7× 40 0.7× 16 0.3× 116 2.3× 36 0.8× 7 340
Candace J. Poole United States 7 234 1.7× 29 0.5× 27 0.5× 55 1.1× 51 1.2× 10 298
Sherif S. Morgan United States 7 178 1.3× 84 1.4× 25 0.5× 100 2.0× 55 1.3× 9 330
Dilys T.H. Leung Australia 9 177 1.3× 38 0.6× 36 0.7× 77 1.5× 110 2.6× 10 340
Liangliang Xu Hong Kong 5 225 1.6× 34 0.6× 107 1.9× 120 2.4× 58 1.3× 6 372
Sylvia Katz Germany 7 231 1.6× 36 0.6× 99 1.8× 67 1.3× 62 1.4× 11 357
Frans A. van Nieuwpoort Netherlands 5 125 0.9× 23 0.4× 38 0.7× 154 3.1× 80 1.9× 5 306

Countries citing papers authored by Aurélie Drouet

Since Specialization
Citations

This map shows the geographic impact of Aurélie Drouet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurélie Drouet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurélie Drouet more than expected).

Fields of papers citing papers by Aurélie Drouet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurélie Drouet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurélie Drouet. The network helps show where Aurélie Drouet may publish in the future.

Co-authorship network of co-authors of Aurélie Drouet

This figure shows the co-authorship network connecting the top 25 collaborators of Aurélie Drouet. A scholar is included among the top collaborators of Aurélie Drouet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurélie Drouet. Aurélie Drouet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Drouet, Aurélie, Ludivine Beaussire, Sophie Coutant, et al.. (2023). Disequilibrium between BRCA1 and BRCA2 Circular and Messenger RNAs Plays a Role in Breast Cancer. Cancers. 15(7). 2176–2176. 2 indexed citations
2.
Morak, Monika, Marta Pineda, Alexandra Martins, et al.. (2022). Splicing analyses for variants in MMR genes: best practice recommendations from the European Mismatch Repair Working Group. European Journal of Human Genetics. 30(9). 1051–1059. 5 indexed citations
3.
Hamieh, Mohamad, Émilie Fauquembergue, Pauline Maby, et al.. (2021). Generation of Pure Highly Functional Human Anti-Tumor Specific Cytotoxic T Lymphocytes With Stem Cell-Like Memory Features for Melanoma Immunotherapy. Frontiers in Immunology. 12. 674276–674276. 5 indexed citations
4.
Soukarieh, Omar, Pascaline Gaildrat, Mohamad Hamieh, et al.. (2016). Exonic Splicing Mutations Are More Prevalent than Currently Estimated and Can Be Predicted by Using In Silico Tools. PLoS Genetics. 12(1). e1005756–e1005756. 117 indexed citations
5.
Tricarico, Rossella, Cristina Mareni, Bryony A. Thompson, et al.. (2016). Assessment of the InSiGHT Interpretation Criteria for the Clinical Classification of 24MLH1andMSH2Gene Variants. Human Mutation. 38(1). 64–77. 24 indexed citations
6.
Hamieh, Mohamad, Aurélie Drouet, Jérôme Leprince, et al.. (2016). Artificial antigen‐presenting cells expressing HLA class II molecules as an effective tool for amplifying human specific memory CD4+ T cells. Immunology and Cell Biology. 94(7). 662–672. 18 indexed citations
7.
Hamieh, Mohamad, C. Abasq, Émilie Fauquembergue, et al.. (2015). Direct Toll‐Like Receptor 8 signaling increases the functional avidity of human CD8+ T lymphocytes generated for adoptive T cell therapy strategies. Immunity Inflammation and Disease. 3(1). 1–13. 5 indexed citations
8.
Bougeard, Gaëlle, Hélène Castel, Héctor Hernández‐Vargas, et al.. (2013). Germline copy number variation of genes involved in chromatin remodelling in families suggestive of Li-Fraumeni syndrome with brain tumours. European Journal of Human Genetics. 21(12). 1369–1376. 23 indexed citations
9.
Thedrez, Aurélie, Jean‐Baptiste Latouche, Florian Cabillic, et al.. (2013). CRTAM Receptor Engagement by Necl-2 on Tumor Cells Triggers Cell Death of Activated Vγ9Vδ2 T Cells. The Journal of Immunology. 190(9). 4868–4876. 12 indexed citations
10.
Fauquembergue, Émilie, Olivier Toutirais, David Tougeron, et al.. (2010). HLA-A*0201-restricted CEA-derived Peptide CAP1 Is Not a Suitable Target for T-cell-based Immunotherapy. Journal of Immunotherapy. 33(4). 402–413. 14 indexed citations
11.
Bohers, Élodie, Nasrin Sarafan‐Vasseur, Aurélie Drouet, et al.. (2008). Gradual reduction of BUBR1 protein levels results in premature sister-chromatid separation then in aneuploidy. Human Genetics. 124(5). 473–478. 34 indexed citations
12.
Drouet, J., et al.. (1985). Blood Donors Positive for HBsAg and Negative for Anti‐HBc Antibody. Vox Sanguinis. 49(1). 26–33. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Małgorzata Krześniak Breakdown of academic impact, for papers by Teri M. Plona Breakdown of academic impact, for papers by Jin Woo Park Breakdown of academic impact, for papers by Christine von Klitzing Breakdown of academic impact, for papers by Candace J. Poole Breakdown of academic impact, for papers by Sherif S. Morgan Breakdown of academic impact, for papers by Dilys T.H. Leung Breakdown of academic impact, for papers by Liangliang Xu Breakdown of academic impact, for papers by Sylvia Katz Breakdown of academic impact, for papers by Frans A. van Nieuwpoort
Rankless by CCL
2026